Table 3.
One-Year and One-Month Post-Operative Outcomes by Mesh Type
| One-year post-operative outcomes | Biologic mesh n = 33 | Synthetic mesh n = 37 | Relative risk (95% CI)a | p | Bayesian posterior probability |
|---|---|---|---|---|---|
| Major complication, no. | |||||
| (%) | |||||
| Overall | 14 (42.4%) | 8 (21.6%) | 1.96 (0.94–4.08) | 0.071 | 95% |
| Mesh infection | 5 (15.2%) | 2 (5.4%) | 2.80 (0.58–13.49) | 0.242 | 86% |
| Recurrence | 10 (30.3%) | 5 (13.5%) | 2.24 (0.85–5.89) | 0.143 | 93% |
| Reoperation | 4 (12.1%) | 3 (8.1%) | 1.49 (0.36–6.19) | 0.699 | 67% |
| One-month post-operative outcomes | Biologic mesh n = 44 | Synthetic mesh n = 43 | Relative risk (95% CI)a | p | Bayesian posterior probability |
| Surgical site infection, no. (%) | 7 (15.9%) | 4 (9.3%) | 1.71 (0.54–5.42) | 0.362 | 79% |
| Seroma, no. (%) | 5 (11.4%) | 5 (11.6%) | 0.98 (0.30–3.14) | 0.977 | 49% |
| Hematoma, no. (%) | 3 (6.8%) | 2 (4.7%) | 1.47 (0.26–8.34) | 0.666 | 63% |
| Wound dehiscence, no. (%) | 11 (25.0%) | 6 (14.0%) | 1.79 (0.73–4.41) | 0.205 | 88% |
| Re-admission, no. (%) | 10 (22.7%) | 4 (9.3%) | 2.44 (0.83–7.20) | 0.105 | 93% |
| Clavien-Dindo | |||||
| complications, no. (%) | |||||
| Overall | 21 (47.7%) | 17 (39.5%) | 1.21 (0.75–1.95) | 0.444 | 76% |
| 1–2 | 16 (36.4%) | 13 (30.2%) | |||
| 3–5 | 5 (11.4%) | 4 (9.3%) | |||
| Days in hospital at 90-days post-operative, (days), median (IQR) | 3.5 (1.8–7.3) | 3.0 (1.0–6.5) | 1.14 (0.95–1.37) | 0.160 | 92% |
CI = confidence interval; IQR = interquartile range.
a
Synthetic mesh represents the control for relative risk calculation.